Andrew Tucker Kuykendall
机构:Moffitt Cancer Center · ORCID:0000-0002-9040-7415
发表论文 575 篇 · 总被引 3236 次 · h-index 27
代表论文
- Genomic profiling for decision-making in post–polycythemia vera and post–essential thrombocythemia myelofibrosis (2026 · Blood · 被引 9)
- POIESIS: a phase III study of add-on navtemadlin in JAK inhibitor-naïve myelofibrosis patients with a suboptimal response to ruxolitinib (2026 · Future Oncology · 被引 3)
- Ruxolitinib treatment for myelofibrosis with anemia: a retrospective assessment of real-world patient characteristics, treatment patterns, and survival (2026 · Leukemia & lymphoma/Leukemia and lymphoma · 被引 2)
- Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images (2026 · Leukemia · 被引 2)
- Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes (2025 · Blood Advances · 被引 2)
- Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation (2026 · Blood Advances · 被引 1)